A moderate increase of the frequency of CD161-expressing CD8+ T cells was also observed within the tumor as compared to blood, and this increase concerned mainly CD161+/dim conventional CD8+ T cells, CD161bright CD8+ MAITs cells being poorly represented. The gene discussed is KLRB1; the disease is neoplasm.